The revised guidance of ASELSAN on consolidated financial results for 2018 are as follows:
Consolidated revenue growth (TL) (*): ≥ 40%
EBITDA (Consolidated and adjusted without foreign exchange rate differences) (*): 19%– 21%
Capital expenditures (Tangible and Intangible): ~ 650 million TL
Ratio of self-funded R&D to sales: %7
(*) Revised.
